DAEWOONG CO.,LTD
003090 | KO
Overview
Corporate Details
- ISIN(s):
- KR7003090008
- LEI:
- Country:
- South Korea
- Address:
- 경기 성남시 중원구 상대원동 223-23, 성남시
- Website:
- https://www.daewoong.co.kr
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-15 00:00 |
Regulatory Filings
투자판단관련주요경영사항(자회사의 주요경영사항)
|
Korean | 14.9 KB | ||
| 2025-09-05 00:00 |
Regulatory Filings
투자판단관련주요경영사항(자회사의 주요경영사항)
|
Korean | 9.0 KB | ||
| 2025-08-14 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 3.7 MB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 4.0 MB | ||
| 2025-07-30 00:00 |
Regulatory Filings
투자판단관련주요경영사항(자회사의 주요경영사항)
|
Korean | 9.5 KB | ||
| 2025-06-02 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 708.5 KB | ||
| 2025-05-16 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.7 KB | ||
| 2025-05-16 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 162.0 KB | ||
| 2025-05-16 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 58.0 KB | ||
| 2025-05-15 00:00 |
Major Shareholding Notification
[기재정정]최대주주등소유주식변동신고서
|
Korean | 54.8 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 2.1 MB | ||
| 2025-05-14 00:00 |
Major Shareholding Notification
[기재정정]최대주주등소유주식변동신고서
|
Korean | 60.7 KB | ||
| 2025-04-16 00:00 |
Capital/Financing Update
단기차입금증가결정(자회사의 주요경영사항)
|
Korean | 11.5 KB | ||
| 2025-04-02 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.0 KB | ||
| 2025-04-01 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 62.4 KB |
Automate Your Workflow. Get a real-time feed of all DAEWOONG CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for DAEWOONG CO.,LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DAEWOONG CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
A vertically integrated European group for the entire hemp and cannabis value chain.
Germany
SBX
Germany
SBX
Biopharma firm developing and commercializing first-in-class therapies for cancer patients.
United States of America
SNDX
United States of America
SNDX
Manufactures radiopharma; provides medical equipment, IT solutions, and services to specialists.
Poland
SNT
Poland
SNT
South Korea
048870
Uses synthetic biology to engineer oral living medicines for rare metabolic disorders.
United States of America
SYBX
United States of America
SYBX
Develops and sells oncology, hematology, and immunology drugs and vaccines globally.
Poland
BML
Poland
BML
Manufactures OTC gastrointestinal medicine and leading infection control products.
Japan
4574
Japan
4574
Provides life science research tools, gene therapies, and CDMO services for improving human health.
Japan
4974
Japan
4974
R&D-driven biopharma creating medicines for Oncology, Rare Diseases, GI, and Neuroscience.
Japan
4502
Japan
4502
Develops therapies for acute pain and anticoagulants for medically supervised settings.
United States of America
TLPH
United States of America
TLPH